| Year |
Citation |
Score |
| 2019 |
van Doorn P, Rosing J, Campello E, Middeldorp S, Simioni P, Meijers JCM, Hackeng TM, Castoldi E. Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIα. Thrombosis and Haemostasis. PMID 31705518 DOI: 10.1055/S-0039-1700516 |
0.467 |
|
| 2018 |
van Doorn P, Rosing J, Duckers C, Hackeng TM, Simioni P, Castoldi E. Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2. Thrombosis and Haemostasis. PMID 29864781 DOI: 10.1055/S-0038-1656549 |
0.475 |
|
| 2018 |
Hackeng TM, van Doorn P, Rosing J, Meijers J, Middeldorp S, Simioni P, Castoldi E. A Plasma-Based Assay to Measure the Susceptibility of Factor V(a) to Inhibition By TFPIα Blood. 132: 1168-1168. DOI: 10.1182/Blood-2018-99-118767 |
0.47 |
|
| 2017 |
Alshaikh NA, Rosing J, Thomassen MCLGD, Castoldi E, Simioni P, Hackeng TM. New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma. Journal of Thrombosis and Haemostasis : Jth. 15: 950-960. PMID 28211163 DOI: 10.1111/Jth.13657 |
0.473 |
|
| 2017 |
Westhoff CL, Pike MC, Cremers S, Eisenberger A, Thomassen S, Rosing J. Endogenous Thrombin Potential Changes during the First Cycle of Oral Contraceptive Use. Contraception. PMID 28088496 DOI: 10.1016/J.Contraception.2017.01.001 |
0.303 |
|
| 2017 |
van Doorn P, Rosing J, Wielders SJ, Hackeng TM, Castoldi E. The C-terminus of tissue factor pathway inhibitor-α inhibits factor V activation by protecting the Arg(1545) cleavage site. Journal of Thrombosis and Haemostasis : Jth. 15: 140-149. PMID 27801970 DOI: 10.1111/Jth.13559 |
0.445 |
|
| 2016 |
Alshaikh N, Rosing J, Thomassen S, Castoldi E, Simioni P, Hackeng TM. New Functional Assays to Selectively Quantify APC- and TFPI-Cofactor Activities of Protein S in Plasma Blood. 128: 717-717. DOI: 10.1182/Blood.V128.22.717.717 |
0.428 |
|
| 2016 |
van Doorn P, Rosing J, Wielders S, Hackeng TM, Castoldi E. The C-Terminus of Tfpiα Inhibits Factor V Activation By Protecting the Arg1545 Cleavage Site Blood. 128: 257-257. DOI: 10.1182/Blood.V128.22.257.257 |
0.453 |
|
| 2015 |
Peraramelli S, Thomassen S, Heinzmann A, Hackeng TM, Hartmann R, Scheiflinger F, Dockal M, Rosing J. Role of exosite binding modulators in the inhibition of fxa by TFPI. Thrombosis and Haemostasis. 115. PMID 26607136 DOI: 10.1160/Th15-04-0354 |
0.407 |
|
| 2015 |
Thomassen MC, Heinzmann AC, Herfs L, Hartmann R, Dockal M, Scheiflinger F, Hackeng TM, Rosing J. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α. Journal of Thrombosis and Haemostasis : Jth. 13: 92-100. PMID 25348176 DOI: 10.1111/Jth.12766 |
0.358 |
|
| 2014 |
Tchaikovski SN, Thomassen MC, Costa SD, Bremme K, Rosing J. Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives. Thrombosis Research. 134: 1032-7. PMID 25260941 DOI: 10.1016/J.Thromres.2014.09.008 |
0.38 |
|
| 2014 |
Peraramelli S, Thomassen S, Heinzmann A, Rosing J, Hackeng TM, Hartmann R, Scheiflinger F, Dockal M. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs. Journal of Thrombosis and Haemostasis : Jth. 12: 1826-37. PMID 25163770 DOI: 10.1111/Jth.12713 |
0.43 |
|
| 2014 |
Omarova F, Uitte de Willige S, Simioni P, Ariëns RA, Bertina RM, Rosing J, Castoldi E. Fibrinogen γ' increases the sensitivity to activated protein C in normal and factor V Leiden plasma. Blood. 124: 1531-8. PMID 24951429 DOI: 10.1182/Blood-2014-02-554055 |
0.623 |
|
| 2014 |
Raps M, Curvers J, Helmerhorst FM, Ballieux BE, Rosing J, Thomassen S, Rosendaal FR, van Vliet HA. Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives. Thrombosis Research. 133: 640-4. PMID 24438944 DOI: 10.1016/J.Thromres.2013.12.041 |
0.341 |
|
| 2014 |
Dockal M, Hartmann R, Fries M, Thomassen MC, Heinzmann A, Ehrlich H, Rosing J, Osterkamp F, Polakowski T, Reineke U, Griessner A, Brandstetter H, Scheiflinger F. Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI). The Journal of Biological Chemistry. 289: 1732-41. PMID 24275667 DOI: 10.1074/Jbc.M113.533836 |
0.379 |
|
| 2013 |
Omarova F, Uitte De Willige S, Ariëns RA, Rosing J, Bertina RM, Castoldi E. Inhibition of thrombin-mediated factor V activation contributes to the anticoagulant activity of fibrinogen γ'. Journal of Thrombosis and Haemostasis : Jth. 11: 1669-78. PMID 23848367 DOI: 10.1111/Jth.12354 |
0.589 |
|
| 2013 |
Raps M, Rosendaal F, Ballieux B, Rosing J, Thomassen S, Helmerhorst F, van Vliet H. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial. Journal of Thrombosis and Haemostasis : Jth. 11: 855-61. PMID 23410231 DOI: 10.1111/Jth.12172 |
0.343 |
|
| 2013 |
Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, Reitsma P, Sandset PM, van Vliet HA. The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI. Thrombosis and Haemostasis. 109: 606-13. PMID 23407778 DOI: 10.1160/Th12-10-0771 |
0.373 |
|
| 2013 |
Peraramelli S, Thomassen S, Heinzmann A, Rosing J, Hackeng TM, Hartmann R, Scheiflinger F, Dockal M. Direct inhibition of factor VIIa by TFPI and TFPI constructs. Journal of Thrombosis and Haemostasis : Jth. 11: 704-14. PMID 23347185 DOI: 10.1111/Jth.12152 |
0.337 |
|
| 2013 |
Dockal M, Hartmann R, Fries M, Prohaska K, Pachlinger R, Polakowski T, Brandstetter J, Rosing J, Scheiflinger F. Crystal Structure Of Tissue Factor Pathway Inhibitor (TFPI) Kunitz Domain 1 and 2 In Complex With An Inhibitory Cyclic Peptide, Blood. 122: 453-453. DOI: 10.1182/Blood.V122.21.453.453 |
0.342 |
|
| 2013 |
Dockal M, Hartmann R, Polakowski T, Brandstetter J, Kammlander W, Panholzer E, Redl C, Osterkamp F, Rosing J, Scheiflinger F. Design Of a Most Efficient Inhibitor Of TFPI By Molecular Fusion Of Two Inhibitory Peptides Blood. 122: 3564-3564. DOI: 10.1182/Blood.V122.21.3564.3564 |
0.356 |
|
| 2013 |
Thomassen S, Heinzmann A, Herfs L, Rosing J, Hackeng TM, Hartmann R, Scheiflinger F, Dockal M. TFPI Expresses Anticoagulant Activity Independent Of TF-FVIIa Blood. 122: 3563-3563. DOI: 10.1182/Blood.V122.21.3563.3563 |
0.439 |
|
| 2012 |
Peraramelli S, Suylen DP, Rosing J, Hackeng TM. The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa. Thrombosis and Haemostasis. 108: 266-76. PMID 22627666 DOI: 10.1160/Th11-12-0902 |
0.339 |
|
| 2012 |
Raps M, Helmerhorst F, Fleischer K, Thomassen S, Rosendaal F, Rosing J, Ballieux B, VAN Vliet H. Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives. Journal of Thrombosis and Haemostasis : Jth. 10: 992-7. PMID 22469296 DOI: 10.1111/J.1538-7836.2012.04720.X |
0.327 |
|
| 2012 |
Peraramelli S, Rosing J, Hackeng TM. TFPI-dependent activities of protein S. Thrombosis Research. 129: S23-6. PMID 22425215 DOI: 10.1016/J.Thromres.2012.02.024 |
0.478 |
|
| 2011 |
Tchaikovski SN, Thomassen MC, Costa SD, Peeters LL, Rosing J. Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia. Thrombosis and Haemostasis. 106: 914-21. PMID 21979881 DOI: 10.1160/Th11-04-0244 |
0.382 |
|
| 2011 |
Sonnevi K, Tchaikovski SN, Holmström M, Rosing J, Bremme K, Lärfars G. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years. Thrombosis and Haemostasis. 106: 901-7. PMID 21947267 DOI: 10.1160/Th11-04-0254 |
0.386 |
|
| 2011 |
Kroh HK, Panizzi P, Tchaikovski S, Baird TR, Wei N, Krishnaswamy S, Tans G, Rosing J, Furie B, Furie BC, Bock PE. Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivo. The Journal of Biological Chemistry. 286: 23345-56. PMID 21531712 DOI: 10.1074/Jbc.M111.230292 |
0.373 |
|
| 2011 |
Castoldi E, Duckers C, Radu C, Spiezia L, Rossetto V, Tagariello G, Rosing J, Simioni P. Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma. Journal of Thrombosis and Haemostasis : Jth. 9: 959-68. PMID 21320286 DOI: 10.1111/J.1538-7836.2011.04237.X |
0.367 |
|
| 2011 |
Castoldi E, Rosing J. Thrombin generation tests. Thrombosis Research. 127: S21-5. PMID 21262433 DOI: 10.1016/S0049-3848(11)70007-X |
0.398 |
|
| 2011 |
Duckers C, Simioni P, Tormene D, Carraro S, Rosing J, Castoldi E. Factor V Leiden pseudo-homozygotes have a more pronounced hypercoagulable state than factor V Leiden homozygotes. Journal of Thrombosis and Haemostasis : Jth. 9: 864-7. PMID 21251207 DOI: 10.1111/J.1538-7836.2011.04205.X |
0.343 |
|
| 2011 |
Dockal M, Brandstetter J, Ludwiczek M, Kontaxis G, Fries M, Thomassen MCLGD, Heinzmann A, Ehrlich HJ, Prohaska K, Hartmann R, Rosing J, Scheiflinger F. Peptides Binding to Kunitz Domain 1 of Tissue Factor Pathway Inhibitor (TFPI) Inhibit All Functions of TFPI and Improve Thrombin Generation of Hemophilia Plasma Blood. 118: 2245-2245. DOI: 10.1182/Blood.V118.21.2245.2245 |
0.366 |
|
| 2011 |
Tchaikovski S, Thomassen M, Costa S, Peeters L, Rosing J. 0.06b Role of protein S and tissue factor pathway inhibitor in the development of APC resistance early in pregnancy Thrombosis Research. 127: S126. DOI: 10.1016/S0049-3848(11)70044-5 |
0.348 |
|
| 2010 |
Nicolaes GA, Bock PE, Segers K, Wildhagen KC, Dahlbäck B, Rosing J. Inhibition of thrombin formation by active site mutated (S360A) activated protein C. The Journal of Biological Chemistry. 285: 22890-900. PMID 20484050 DOI: 10.1074/Jbc.M110.131029 |
0.822 |
|
| 2010 |
Castoldi E, Maurissen LF, Tormene D, Spiezia L, Gavasso S, Radu C, Hackeng TM, Rosing J, Simioni P. Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiency. Haematologica. 95: 1563-71. PMID 20421270 DOI: 10.3324/Haematol.2010.021923 |
0.375 |
|
| 2010 |
Castoldi E, Maurissen LF, Tormene D, Spiezia L, Gavasso S, Radu C, Hackeng TM, Rosing J, Simioni P. Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from mixed type I/III families. Haematologica. PMID 20378562 DOI: 10.3324/Haematol.2009.021923 |
0.356 |
|
| 2010 |
Tchaikovski SN, Rosing J. Mechanisms of estrogen-induced venous thromboembolism. Thrombosis Research. 126: 5-11. PMID 20163835 DOI: 10.1016/J.Thromres.2010.01.045 |
0.364 |
|
| 2010 |
Segers O, van Oerle Rv, ten Cate Ht, Rosing J, Castoldi E. Thrombin generation as an intermediate phenotype for venous thrombosis. Thrombosis and Haemostasis. 103: 114-22. PMID 20062924 DOI: 10.1160/Th09-06-0356 |
0.366 |
|
| 2010 |
Castoldi E, Rosing J. APC resistance: biological basis and acquired influences. Journal of Thrombosis and Haemostasis : Jth. 8: 445-53. PMID 20002539 DOI: 10.1111/J.1538-7836.2009.03711.X |
0.406 |
|
| 2010 |
Castoldi E, Simioni P, Tormene D, Rosing J, Hackeng TM. Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma. Journal of Thrombosis and Haemostasis : Jth. 8: 294-300. PMID 20002538 DOI: 10.1111/J.1538-7836.2009.03712.X |
0.384 |
|
| 2010 |
Duckers C, Simioni P, Spiezia L, Radu C, Dabrilli P, Gavasso S, Rosing J, Castoldi E. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms. Blood. 115: 879-86. PMID 19861681 DOI: 10.1182/Blood-2009-08-237719 |
0.385 |
|
| 2010 |
Sonnevi K, Tchaikovski SN, Bremme K, Holmstrom M, Rosing J, Larfars G. High Thrombin Generation Measured In the Presence of Activated Protein C Is Associated with An Increased Risk of Recurrence Among Women 18–64 Years After a First Event of VTE Blood. 116: 154-154. DOI: 10.1182/Blood.V116.21.154.154 |
0.348 |
|
| 2009 |
Hackeng TM, Rosing J. Protein S as cofactor for TFPI. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 2015-20. PMID 19661488 DOI: 10.1161/Atvbaha.108.177436 |
0.466 |
|
| 2009 |
Hartmann R, Dockal M, Kammlander W, Panholzer E, Nicolaes GA, Fiedler C, Rosing J, Scheiflinger F. Factor IX mutants with enhanced catalytic activity. Journal of Thrombosis and Haemostasis : Jth. 7: 1656-62. PMID 19656280 DOI: 10.1111/J.1538-7836.2009.03560.X |
0.785 |
|
| 2009 |
Hackeng TM, Maurissen LF, Castoldi E, Rosing J. Regulation of TFPI function by protein S. Journal of Thrombosis and Haemostasis : Jth. 7: 165-8. PMID 19630792 DOI: 10.1111/J.1538-7836.2009.03363.X |
0.449 |
|
| 2009 |
Duckers C, Simioni P, Rosing J, Castoldi E. Advances in understanding the bleeding diathesis in factor V deficiency. British Journal of Haematology. 146: 17-26. PMID 19438479 DOI: 10.1111/J.1365-2141.2009.07708.X |
0.381 |
|
| 2009 |
van Vliet HA, Tchaikovski SN, Rosendaal FR, Rosing J, Helmerhorst FM. The effect of the levonorgestrel-releasing intrauterine system on the resistance to activated protein C (APC). Thrombosis and Haemostasis. 101: 691-5. PMID 19350113 DOI: 10.1160/Th08-09-0621 |
0.315 |
|
| 2009 |
Tchaikovski SN, van Vlijmen BJ, Cleuren AC, Thomassen MC, Tchaikovski V, Tans G, Rosing J. Pregnancy-associated changes in the hemostatic system in wild-type and factor V Leiden mice. Journal of Thrombosis and Haemostasis : Jth. 7: 312-8. PMID 19036061 DOI: 10.1111/J.1538-7836.2008.03240.X |
0.383 |
|
| 2009 |
Fleischer K, van Vliet HA, Rosendaal FR, Rosing J, Tchaikovski S, Helmerhorst FM. Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study. Thrombosis Research. 123: 429-35. PMID 18829069 DOI: 10.1016/J.Thromres.2008.04.022 |
0.341 |
|
| 2008 |
Marchetti M, Castoldi E, Spronk HM, van Oerle R, Balducci D, Barbui T, Rosing J, Ten Cate H, Falanga A. Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera. Blood. 112: 4061-8. PMID 18768782 DOI: 10.1182/Blood-2008-06-164087 |
0.407 |
|
| 2008 |
Duckers C, Simioni P, Spiezia L, Radu C, Gavasso S, Rosing J, Castoldi E. Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. Blood. 112: 3615-23. PMID 18695002 DOI: 10.1182/Blood-2008-06-162453 |
0.393 |
|
| 2008 |
Rosing J, Maurissen LF, Tchaikovski SN, Tans G, Hackeng TM. Protein S is a cofactor for tissue factor pathway inhibitor. Thrombosis Research. 122: S60-3. PMID 18691502 DOI: 10.1016/S0049-3848(08)70021-5 |
0.445 |
|
| 2008 |
Segers K, Dahlbäck B, Rosing J, Nicolaes GA. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin. The Journal of Biological Chemistry. 283: 22573-81. PMID 18519572 DOI: 10.1074/Jbc.M801724200 |
0.806 |
|
| 2008 |
Maurissen LF, Thomassen MC, Nicolaes GA, Dahlbäck B, Tans G, Rosing J, Hackeng TM. Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood. 111: 3034-41. PMID 18160668 DOI: 10.1182/Blood-2007-06-089987 |
0.811 |
|
| 2008 |
Scheiflinger F, Dockal M, Rosing J, Kerschbaumer RJ. Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies. Journal of Thrombosis and Haemostasis : Jth. 6: 315-22. PMID 18088341 DOI: 10.1111/J.1538-7836.2008.02868.X |
0.444 |
|
| 2008 |
van Vliet HA, Bertina RM, Dahm AE, Rosendaal FR, Rosing J, Sandset PM, Helmerhorst FM. Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor. Journal of Thrombosis and Haemostasis : Jth. 6: 346-51. PMID 18067603 DOI: 10.1111/J.1538-7836.2008.02863.X |
0.581 |
|
| 2008 |
Dielis AW, Castoldi E, Spronk HM, van Oerle R, Hamulyák K, Ten Cate H, Rosing J. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. Journal of Thrombosis and Haemostasis : Jth. 6: 125-31. PMID 17988231 DOI: 10.1111/J.1538-7836.2007.02824.X |
0.453 |
|
| 2008 |
van Vliet HA, Rodrigues SP, Snieders MN, van der Meer FJ, Frolich M, Rosendaal FR, Rosing J, Helmerhorst FM. Sensitivity to activated protein C during the menstrual cycle in women with and without factor VLeiden. Thrombosis Research. 121: 757-61. PMID 17936879 DOI: 10.1016/J.Thromres.2007.08.010 |
0.368 |
|
| 2007 |
Tchaikovski SN, van Vliet HA, Thomassen MC, Bertina RM, Rosendaal FR, Sandset PM, Helmerhorst FM, Tans G, Rosing J. Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography. Thrombosis and Haemostasis. 98: 1350-6. PMID 18064335 DOI: 10.1160/Th07-07-0439 |
0.547 |
|
| 2007 |
van Rooijen M, Silveira A, Thomassen S, Odeberg J, Hamsten A, Rosing J, Bremme K. APC resistance during the normal menstrual cycle. Thrombosis and Haemostasis. 98: 1246-51. PMID 18064321 DOI: 10.1160/Th07-02-0139 |
0.326 |
|
| 2007 |
Segers K, Dahlbäck B, Bock PE, Tans G, Rosing J, Nicolaes GA. The role of thrombin exosites I and II in the activation of human coagulation factor V. The Journal of Biological Chemistry. 282: 33915-24. PMID 17878169 DOI: 10.1074/Jbc.M701123200 |
0.811 |
|
| 2007 |
Tchaikovski SN, VAN Vlijmen BJ, Rosing J, Tans G. Development of a calibrated automated thrombography based thrombin generation test in mouse plasma. Journal of Thrombosis and Haemostasis : Jth. 5: 2079-86. PMID 17666016 DOI: 10.1111/J.1538-7836.2007.02719.X |
0.4 |
|
| 2007 |
Segers K, Sperandio O, Sack M, Fischer R, Miteva MA, Rosing J, Nicolaes GA, Villoutreix BO. Design of protein membrane interaction inhibitors by virtual ligand screening, proof of concept with the C2 domain of factor V. Proceedings of the National Academy of Sciences of the United States of America. 104: 12697-702. PMID 17646652 DOI: 10.1073/Pnas.0701051104 |
0.755 |
|
| 2007 |
Castoldi E, Simioni P, Tormene D, Thomassen MC, Spiezia L, Gavasso S, Rosing J. Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia. Journal of Thrombosis and Haemostasis : Jth. 5: 971-9. PMID 17461930 DOI: 10.1111/J.1538-7836.2007.02448.X |
0.35 |
|
| 2007 |
Kroh HK, Tans G, Nicolaes GA, Rosing J, Bock PE. Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation. The Journal of Biological Chemistry. 282: 16095-104. PMID 17430903 DOI: 10.1074/Jbc.M610577200 |
0.776 |
|
| 2007 |
Castoldi E, Lunghi B, Rosing J, Bernardi F. Factor V Kuwait alias factor V R3: a rare polymorphism of uncertain functional significance. Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre. 16: 244-5; author reply . PMID 17409764 DOI: 10.1159/000100400 |
0.345 |
|
| 2007 |
van Rooijen M, Silveira A, Thomassen S, Hansson LO, Rosing J, Hamsten A, Bremme K. Rapid activation of haemostasis after hormonal emergency contraception. Thrombosis and Haemostasis. 97: 15-20. PMID 17200765 DOI: 10.1160/Th06-09-0540 |
0.404 |
|
| 2007 |
Meesters EW, Hansen H, Spronk HM, Hamulyak K, Rosing J, Rowshani AT, ten Berge IJ, ten Cate H. The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 18: 21-8. PMID 17179822 DOI: 10.1097/01.Mbc.0000256022.01900.C2 |
0.382 |
|
| 2007 |
Brandts A, van Hylckama Vlieg A, Rosing J, Baglin TP, Rosendaal FR. The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein C. Journal of Thrombosis and Haemostasis : Jth. 5: 416-8. PMID 17116237 DOI: 10.1111/J.1538-7836.2007.02321.X |
0.38 |
|
| 2007 |
Dielis A, Castoldi E, Spronk H, van Oerle R, Hamulyák K, Rosing J, ten Cate H. COAGULATION FACTORS AND THE PROTEIN C SYSTEM AS DETERMINANTS OF THROMBIN GENERATION Journal of Thrombosis and Haemostasis. 5: P-T-067-P-T-067. DOI: 10.1111/J.1538-7836.2007.Tb01825.X |
0.402 |
|
| 2007 |
Maurissen L, Thomassen S, Nicolaes G, Dahlbäck B, Tans G, Rosing J, Hackeng T. PROTEIN S-C4BP COMPLEX STIMULATES ACTIVATED PROTEIN C-MEDIATED INACTIVATION AT R306 BUT INHIBITS INACTIVATION AT R506 IN FACTOR VA Journal of Thrombosis and Haemostasis. 5: P-M-082-P-M-082. DOI: 10.1111/J.1538-7836.2007.Tb01004.X |
0.793 |
|
| 2007 |
Marchetti M, Castoldi E, Spronk H, Balducci D, Barbui T, Rosing J, ten Cate H, Falanga A. ACQUIRED RESISTANCE TO ACTIVATED PROTEIN C (APC) IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA (ET) Journal of Thrombosis and Haemostasis. 5: O-M-006-O-M-006. DOI: 10.1111/J.1538-7836.2007.Tb00833.X |
0.349 |
|
| 2007 |
Rooijen MV, Bremme K, Rosing J, Silveira A, Thomassen S. 69 Rapid activation of haemostasis after hormonal emergency contraception Thrombosis Research. 119. DOI: 10.1016/S0049-3848(07)70114-7 |
0.309 |
|
| 2006 |
Tchaikovski S, Tans G, Rosing J. Venous thrombosis and oral contraceptives: current status. Women's Health (London, England). 2: 761-72. PMID 19803829 DOI: 10.2217/17455057.2.5.761 |
0.356 |
|
| 2006 |
Nicolaes GA, Hackeng TM, Segers K, Rosing J. A structural model of the SHBG domain of human variant protein S Heerlen. Thrombosis and Haemostasis. 96: 538-40. PMID 17003935 DOI: 10.1160/Th06-07-0361 |
0.736 |
|
| 2006 |
Segers K, Rosing J, Nicolaes GA. Structural models of the snake venom factor V activators from Daboia russelli and Daboia lebetina. Proteins. 64: 968-84. PMID 16807918 DOI: 10.1002/Prot.21051 |
0.799 |
|
| 2006 |
Hemelaar M, Rosing J, Kenemans P, Thomassen MC, Braat DD, van der Mooren MJ. Less effect of intranasal than oral hormone therapy on factors associated with venous thrombosis risk in healthy postmenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 1660-6. PMID 16645152 DOI: 10.1161/01.Atv.0000224325.96659.53 |
0.342 |
|
| 2006 |
Brugge JM, Tans G, Rosing J, Castoldi E. Protein S levels modulate the activated protein C resistance phenotype induced by elevated prothrombin levels. Thrombosis and Haemostasis. 95: 236-42. PMID 16493484 DOI: 10.1160/Th05-08-0582 |
0.424 |
|
| 2006 |
Hackeng TM, Seré KM, Tans G, Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proceedings of the National Academy of Sciences of the United States of America. 103: 3106-11. PMID 16488980 DOI: 10.1073/Pnas.0504240103 |
0.448 |
|
| 2006 |
Seré KM, Willems GM, Rosing J, Hackeng TM. Protein S multimers are generated in vitro and affect protein S structure-function analyses. Seminars in Hematology. 43: S111-20. PMID 16427377 DOI: 10.1053/J.Seminhematol.2005.11.027 |
0.365 |
|
| 2006 |
Nicolaes GAF, Rosing J. Activation of factor V by venom proteases Toxin Reviews. 25: 217-234. DOI: 10.1080/15569540600567289 |
0.458 |
|
| 2005 |
Brugge JM, Simioni P, Bernardi F, Tormene D, Lunghi B, Tans G, Pagnan A, Rosing J, Castoldi E. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation. Journal of Thrombosis and Haemostasis : Jth. 3: 2695-702. PMID 16359508 DOI: 10.1111/J.1538-7836.2005.01634.X |
0.409 |
|
| 2005 |
de Visser MC, van Hylckama Vlieg A, Tans G, Rosing J, Dahm AE, Sandset PM, Rosendaal FR, Bertina RM. Determinants of the APTT- and ETP-based APC sensitivity tests. Journal of Thrombosis and Haemostasis : Jth. 3: 1488-94. PMID 15978106 DOI: 10.1111/J.1538-7836.2005.01430.X |
0.594 |
|
| 2005 |
Simioni P, Castoldi E, Lunghi B, Tormene D, Rosing J, Bernardi F. An underestimated combination of opposites resulting in enhanced thrombotic tendency. Blood. 106: 2363-5. PMID 15961511 DOI: 10.1182/Blood-2005-04-1461 |
0.351 |
|
| 2005 |
Koenen RR, Christella M, Thomassen LG, Tans G, Rosing J, Hackeng TM. Effect of oral contraceptives on the anticoagulant activity of protein S in plasma. Thrombosis and Haemostasis. 93: 853-9. PMID 15886799 DOI: 10.1160/Th04-11-0762 |
0.461 |
|
| 2005 |
Galli M, Willems GM, Rosing J, Janssen RM, Govers-Riemslag JW, Comfurius P, Barbui T, Zwaal RF, Bevers EM. Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C. British Journal of Haematology. 129: 240-7. PMID 15813852 DOI: 10.1111/J.1365-2141.2005.05438.X |
0.353 |
|
| 2005 |
van Vliet HA, Frolich M, Christella M, Thomassen LG, Doggen CJ, Rosendaal FR, Rosing J, Helmerhorst FM. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens. Human Reproduction (Oxford, England). 20: 563-8. PMID 15539435 DOI: 10.1093/Humrep/Deh612 |
0.334 |
|
| 2004 |
Duschek EJ, Neele SJ, Thomassen MC, Rosing J, Netelenbos C. Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 15: 649-55. PMID 15613919 DOI: 10.1097/00001721-200412000-00004 |
0.302 |
|
| 2004 |
van Vliet HA, Winkel TA, Noort I, Rosing J, Rosendaal FR. Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate. Journal of Thrombosis and Haemostasis : Jth. 2: 2060-2. PMID 15550051 DOI: 10.1111/J.1538-7836.2004.00983.X |
0.31 |
|
| 2004 |
Seré KM, Rosing J, Hackeng TM. Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance. Blood. 104: 3624-30. PMID 15292065 DOI: 10.1182/Blood-2004-03-1146 |
0.456 |
|
| 2004 |
Kerschbaumer RJ, Riedrich K, Kral M, Varadi K, Dorner F, Rosing J, Scheiflinger F. An antibody specific for coagulation factor IX enhances the activity of the intrinsic factor X-activating complex. The Journal of Biological Chemistry. 279: 40445-50. PMID 15265864 DOI: 10.1074/Jbc.M405966200 |
0.429 |
|
| 2004 |
Castoldi E, Rosing J. Factor V Leiden: a disorder of factor V anticoagulant function. Current Opinion in Hematology. 11: 176-81. PMID 15257017 DOI: 10.1097/01.Moh.0000130315.41033.32 |
0.461 |
|
| 2004 |
Nicolaes GA, Sørensen KW, Friedrich U, Tans G, Rosing J, Autin L, Dahlbäck B, Villoutreix BO. Altered inactivation pathway of factor Va by activated protein C in the presence of heparin. European Journal of Biochemistry / Febs. 271: 2724-36. PMID 15206937 DOI: 10.1111/J.1432-1033.2004.04201.X |
0.793 |
|
| 2004 |
Koenen RR, Gomes L, Tans G, Rosing J, Hackeng TM. The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities. Thrombosis and Haemostasis. 91: 1105-14. PMID 15175796 DOI: 10.1160/Th04-02-0082 |
0.401 |
|
| 2004 |
Sørensen KW, Nicolaes GA, Villoutreix BO, Yamazaki T, Tans G, Rosing J, Dahlbäck B. Functional properties of recombinant factor V mutated in a potential calcium-binding site. Biochemistry. 43: 5803-10. PMID 15134454 DOI: 10.1021/Bi0361362 |
0.798 |
|
| 2004 |
Nap AW, Hamulyak K, van Oerle R, van Pampus LC, Spaanderman ME, Damoiseaux J, Rosing J, Peeters LL. Performance of a novel test to quantify activated protein C resistance in women with a history of pre-eclampsia. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 113: 26-30. PMID 15036706 DOI: 10.1016/S0301-2115(03)00329-4 |
0.371 |
|
| 2004 |
Castoldi E, Brugge JM, Nicolaes GA, Girelli D, Tans G, Rosing J. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations. Blood. 103: 4173-9. PMID 14976057 DOI: 10.1182/Blood-2003-10-3578 |
0.794 |
|
| 2004 |
Miteva MA, Brugge JM, Rosing J, Nicolaes GAF, Villoutreix BO. Theoretical and Experimental Study of the D2194G Mutation in the C2 Domain of Coagulation Factor V Biophysical Journal. 86: 488-498. PMID 14695293 DOI: 10.1016/S0006-3495(04)74127-2 |
0.365 |
|
| 2004 |
van der Neut Kolfschoten M, Dirven RJ, Vos HL, Tans G, Rosing J, Bertina RM. Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679. The Journal of Biological Chemistry. 279: 6567-75. PMID 14660667 DOI: 10.1074/Jbc.M308574200 |
0.614 |
|
| 2004 |
Kemmeren JM, Algra A, Meijers JC, Tans G, Bouma BN, Curvers J, Rosing J, Grobbee DE. Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial. Blood. 103: 927-33. PMID 14551147 DOI: 10.1182/Blood-2003-04-1285 |
0.442 |
|
| 2003 |
Tans G, Bouma BN, Büller HR, Rosing J. Changes of hemostatic variables during oral contraceptive use. Seminars in Vascular Medicine. 3: 61-8. PMID 15199493 DOI: 10.1055/S-2003-38333 |
0.399 |
|
| 2003 |
Toorians AWFT, Thomassen MCLGD, Zweegman S, Magdeleyns EJP, Tans G, Gooren LJG, Rosing J. Venous Thrombosis and Changes of Hemostatic Variables during Cross-Sex Hormone Treatment in Transsexual People Journal of Clinical Endocrinology and Metabolism. 88: 5723-5729. PMID 14671159 DOI: 10.1210/Jc.2003-030520 |
0.381 |
|
| 2003 |
Castoldi E, Govers-Riemslag JW, Pinotti M, Bindini D, Tans G, Berrettini M, Mazzucconi MG, Bernardi F, Rosing J. Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation. Blood. 102: 4014-20. PMID 12881304 DOI: 10.1182/Blood-2003-04-1199 |
0.428 |
|
| 2003 |
Tans G, van Hylckama Vlieg A, Thomassen MC, Curvers J, Bertina RM, Rosing J, Rosendaal FR. Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women. British Journal of Haematology. 122: 465-70. PMID 12877675 DOI: 10.1046/J.1365-2141.2003.04443.X |
0.526 |
|
| 2003 |
Koenen RR, Tans G, van Oerle R, Hamulyák K, Rosing J, Hackeng TM. The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation. Blood. 102: 1686-92. PMID 12730108 DOI: 10.1182/Blood-2003-02-0620 |
0.449 |
|
| 2003 |
Nijziel MR, van Oerle R, Christella M, Thomassen LG, van Pampus EC, Hamulyák K, Tans G, Rosing J. Acquired resistance to activated protein C in breast cancer patients. British Journal of Haematology. 120: 117-22. PMID 12492586 DOI: 10.1046/J.1365-2141.2003.03987.X |
0.334 |
|
| 2003 |
Hemker HC, Rosing J. Pathophysiology of Haemostasis and Thrombosis: Editorial Pathophysiology of Haemostasis and Thrombosis. 33: 1. DOI: 10.1159/000071634 |
0.402 |
|
| 2002 |
Post MS, Rosing J, Van Der Mooren MJ, Zweegman S, Van Baal WM, Kenemans P, Stehouwer CD. Increased resistance to activated protein C after short-term oral hormone replacement therapy in healthy post-menopausal women. British Journal of Haematology. 119: 1017-23. PMID 12472583 DOI: 10.1046/J.1365-2141.2002.03957.X |
0.338 |
|
| 2002 |
Govers-Riemslag JW, Castoldi E, Nicolaes GA, Tans G, Rosing J. Reduced factor V concentration and altered FV1/FV2 ratio do not fully explain R2-associated APC-resistance. Thrombosis and Haemostasis. 88: 444-9. PMID 12353074 DOI: 10.1055/S-0037-1613236 |
0.765 |
|
| 2002 |
Curvers J, Thomassen MC, Rimmer J, Hamulyak K, van der Meer J, Tans G, Preston FE, Rosing J. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thrombosis and Haemostasis. 88: 5-11. PMID 12152677 DOI: 10.1055/S-0037-1613145 |
0.407 |
|
| 2002 |
van der Neut Kolfschoten M, Dirven RJ, Tans G, Rosing J, Vos HL, Bertina RM. The activated protein C (APC)-resistant phenotype of APC cleavage site mutants of recombinant factor V in a reconstituted plasma model. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 13: 207-15. PMID 11943934 DOI: 10.1097/00001721-200204000-00006 |
0.504 |
|
| 2002 |
Curvers J, Christella M, Thomassen LG, de Ronde H, Bertina RM, Rosendaal FR, Tans G, Rosing J. Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay. Thrombosis and Haemostasis. 87: 483-92. PMID 11924538 DOI: 10.1055/S-0037-1613029 |
0.584 |
|
| 2002 |
Rosing J, Hemker HC. Supramolecular biology Pathophysiology of Haemostasis and Thrombosis. 32: 1. DOI: 10.1159/000057281 |
0.352 |
|
| 2001 |
Rosing J, Govers-Riemslag JWP, Yukelson L, Tans G. Factor V activation and inactivation by venom proteases Haemostasis. 31: 241-246. PMID 11910191 DOI: 10.1159/000048069 |
0.476 |
|
| 2001 |
Tans G, Rosing J. Snake venom activators of factor X: An overview Haemostasis. 31: 225-233. PMID 11910189 DOI: 10.1159/000048067 |
0.399 |
|
| 2001 |
Curvers J, Nap AW, Thomassen MC, Nienhuis SJ, Hamulyák K, Evers JL, Tans G, Rosing J. Effect of in vitro fertilization treatment and subsequent pregnancy on the protein C pathway. British Journal of Haematology. 115: 400-7. PMID 11703342 DOI: 10.1046/J.1365-2141.2001.03118.X |
0.371 |
|
| 2001 |
Seré KM, Janssen MP, Willems GM, Tans G, Rosing J, Hackeng TM. Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity Biochemistry. 40: 8852-8860. PMID 11467946 DOI: 10.1021/Bi002500A |
0.418 |
|
| 2001 |
Curvers J, Nienhuis SJ, Nap AW, Hamulyák K, Evers JL, Rosing J. Activated protein C resistance during in vitro fertilization treatment. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 95: 222-4. PMID 11301176 DOI: 10.1016/S0301-2115(00)00495-4 |
0.379 |
|
| 2001 |
Rosing J, Curvers J, Tans G. Oral contraceptives, thrombosis and haemostasis European Journal of Obstetrics Gynecology and Reproductive Biology. 95: 193-197. PMID 11301170 DOI: 10.1016/S0301-2115(00)00489-9 |
0.366 |
|
| 2001 |
Hackeng TM, Rosing JAN, Spronk HMH, Vermeer C. Total chemical synthesis of human matrix Gla protein Protein Science. 10: 864-870. PMID 11274477 DOI: 10.1110/Ps.44701 |
0.312 |
|
| 2001 |
Hoekema L, Castoldi E, Tans G, Girelli D, Gemmati D, Bernardi F, Rosing J. Functional properties of factor V and factor Va encoded by the R2-gene Thrombosis and Haemostasis. 85: 75-81. PMID 11204592 DOI: 10.1055/S-0037-1612907 |
0.37 |
|
| 2001 |
Kini RM, Morita T, Rosing J. Classification and Nomenclature of Prothrombin Activators Isolated from Snake Venoms: On behalf of the Registry of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thrombosis and Haemostasis. 86: 710-711. DOI: 10.1055/S-0037-1616108 |
0.346 |
|
| 2000 |
Hoekema L, Rosing J, Tans G. An assay to quantify the two plasma isoforms of factor V Thrombosis and Haemostasis. 84: 1066-1071. PMID 11154115 DOI: 10.1055/S-0037-1614172 |
0.415 |
|
| 2000 |
Van de Poel RHL, Meijers JCM, Rosing J, Tans G, Bouma BN. C4b-binding protein protects coagulation factor Va from inactivation by activated protein C Biochemistry. 39: 14543-14548. PMID 11087409 DOI: 10.1021/Bi0006058 |
0.384 |
|
| 2000 |
Tans G, Curvers J, Middeldorp S, Thomassen MCLGD, Meijers JCM, Prins MH, Bouma BN, Büller HR, Rosing J. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways Thrombosis and Haemostasis. 84: 15-21. PMID 10928463 DOI: 10.1055/S-0037-1613960 |
0.416 |
|
| 2000 |
Meijers JCM, Middeldorp S, Tekelenburg W, Van Den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis. A randomized cross-over study of two low-dose oral contraceptives Thrombosis and Haemostasis. 84: 9-14. PMID 10928462 DOI: 10.1055/S-0037-1613959 |
0.431 |
|
| 2000 |
Middeldorp S, Meijers JCM, Van Den Ende AE, Van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: A cross-over study Thrombosis and Haemostasis. 84: 4-8. PMID 10928461 DOI: 10.1055/S-0037-1613958 |
0.42 |
|
| 2000 |
Castoldi E, Rosing J, Girelli D, Hoekema L, Lunghi B, Mingozzi F, Ferraresi P, Friso S, Corrocher R, Tans G, Bernardi F. Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma Thrombosis and Haemostasis. 83: 362-365. PMID 10744138 DOI: 10.1055/S-0037-1613821 |
0.306 |
|
| 1999 |
Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LGD, Nicolaes GAF, Meijers JCM, Bouma BN, Büller HR, Prins MH, Tans G. Low-dose oral contraceptives and acquired resistance to activated protein C: A randomised cross-over study Lancet. 354: 2036-2040. PMID 10636369 DOI: 10.1016/S0140-6736(99)06092-4 |
0.36 |
|
| 1999 |
Heeb MJ, Kojima Y, Rosing J, Tans G, Griffin JH. C-terminal residues 621-635 of protein S are essential for binding to factor Va Journal of Biological Chemistry. 274: 36187-36192. PMID 10593904 DOI: 10.1074/Jbc.274.51.36187 |
0.355 |
|
| 1999 |
Rosing J, Tans G. Effects of oral contraceptives on hemostasis and thrombosis American Journal of Obstetrics and Gynecology. 180: S375-S382. PMID 10368524 DOI: 10.1016/S0002-9378(99)70699-X |
0.445 |
|
| 1999 |
Curvers J, Thomassen MC, Nicolaes GA, Van Oerle R, Hamulyak K, Hemker HC, Tans G, Rosing J. Acquired APC resistance and oral contraceptives: differences between two functional tests. British Journal of Haematology. 105: 88-94. PMID 10233368 DOI: 10.1111/J.1365-2141.1999.01302.X |
0.81 |
|
| 1998 |
Govers-Riemslag JWP, Johnsen L, Petrovan RJ, Rosing J, Tans G. A kinetic assay to determine prothrombin binding to membranes Thrombosis Research. 92: 239-247. PMID 9851816 DOI: 10.1016/S0049-3848(98)00144-3 |
0.36 |
|
| 1998 |
Rosing J, Hemker HC, Tans G. Molecular biology and pathophysiology of APC resistance: current insights and clinical implications. Seminars in Thrombosis and Hemostasis. 24: 329-35. PMID 9763350 DOI: 10.1055/S-2007-996021 |
0.613 |
|
| 1998 |
Petrovan RJ, Govers-Riemslag JW, Nowak G, Hemker HC, Tans G, Rosing J. Autocatalytic peptide bond cleavages in prothrombin and meizothrombin. Biochemistry. 37: 1185-91. PMID 9477942 DOI: 10.1021/Bi971948H |
0.539 |
|
| 1998 |
Rosing J, Tans G. Factor V. The International Journal of Biochemistry & Cell Biology. 29: 1123-6. PMID 9438374 DOI: 10.1016/s1357-2725(97)00040-x |
0.376 |
|
| 1997 |
Petrovan RJ, Govers-Riemslag JW, Nowak G, Hemker HC, Rosing J, Tans G. Purification and characterization of multisquamase, the prothrombin activator present in Echis multisquamatus venom. Thrombosis Research. 88: 309-16. PMID 9526951 DOI: 10.1016/S0049-3848(97)00258-2 |
0.578 |
|
| 1997 |
Heemskerk JW, Feijge MA, Henneman L, Rosing J, Hemker HC. The Ca2+-mobilizing potency of alpha-thrombin and thrombin-receptor-activating peptide on human platelets -- concentration and time effects of thrombin-induced Ca2+ signaling. European Journal of Biochemistry / Febs. 249: 547-55. PMID 9370366 DOI: 10.1111/J.1432-1033.1997.00547.X |
0.488 |
|
| 1997 |
Schramm W, Heinbmann LAJ, Rosing J, Hemker HC, Tans G. Oral contraceptives and venous thromboembolism: Acquired APC resistance? [1] (multiple letters) British Journal of Haematology. 98: 491-492. PMID 9266957 |
0.442 |
|
| 1997 |
Tans G, Nicolaes GAF, Rosing J. Regulation of thrombin formation by activated protein C: Effect of the factor V Leiden mutation Seminars in Hematology. 34: 244-255. PMID 9241709 |
0.392 |
|
| 1997 |
Rosing J, Tans G. Coagulation factor V: An old star shines again Thrombosis and Haemostasis. 78: 427-433. PMID 9198191 DOI: 10.1055/S-0038-1657564 |
0.483 |
|
| 1997 |
Rosing J, Tans G, Nicolaes GA, Thomassen MC, van Oerle R, van der Ploeg PM, Heijnen P, Hamulyak K, Hemker HC. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. British Journal of Haematology. 97: 233-8. PMID 9136971 DOI: 10.1046/J.1365-2141.1997.192707.X |
0.789 |
|
| 1997 |
Van Oerle R, Van Pampus L, Tans G, Rosing J, Hamulyák K. The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance American Journal of Clinical Pathology. 107: 521-526. PMID 9128263 DOI: 10.1093/Ajcp/107.5.521 |
0.41 |
|
| 1997 |
Hoekema L, Nicolaes GA, Hemker HC, Tans G, Rosing J. Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways. Biochemistry. 36: 3331-5. PMID 9116011 DOI: 10.1021/Bi9623284 |
0.819 |
|
| 1997 |
Nicolaes GA, Thomassen MC, Tans G, Rosing J, Hemker HC. Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 8: 28-38. PMID 9105635 DOI: 10.1097/00001721-199701000-00006 |
0.794 |
|
| 1996 |
Hackeng TM, Tans G, Koppelman SJ, De Groot PG, Rosing J, Bouma BN. Protein C activation on endothelial cells by prothrombin activation products generated in situ: Meizothrombin is a better protein C activator than α-thrombin Biochemical Journal. 319: 399-405. PMID 8912673 DOI: 10.1042/bj3190399 |
0.322 |
|
| 1996 |
Nicolaes GA, Thomassen MC, van Oerle R, Hamulyak K, Hemker HC, Tans G, Rosing J. A prothrombinase-based assay for detection of resistance to activated protein C. Thrombosis and Haemostasis. 76: 404-10. PMID 8883278 DOI: 10.1055/S-0038-1650591 |
0.819 |
|
| 1996 |
Várodi K, Rosing J, Tans G, Pabinger I, Keil B, Schwarz HP. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: Influence of the factor V(R506Q) mutation Thrombosis and Haemostasis. 76: 208-214. PMID 8865533 DOI: 10.1055/S-0038-1650556 |
0.478 |
|
| 1995 |
Nicolaes GAF, Tans G, Thomassen MCLGD, Hemker HC, Pabinger I, Varadi K, Schwarz HP, Rosing J. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C Journal of Biological Chemistry. 270: 21158-21166. PMID 7673148 DOI: 10.1074/Jbc.270.36.21158 |
0.634 |
|
| 1995 |
Rosing J, Hoekema L, Nicolaes GAF, Thomassen MCLGD, Hemker HC, Varadi K, Schwarz HP, Tans G. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C Journal of Biological Chemistry. 270: 27852-27858. PMID 7499257 DOI: 10.1074/Jbc.270.46.27852 |
0.641 |
|
| 1995 |
Varadi K, Rosing J, Tans G, Schwarz HP. Influence of factor V and factor Va on APC-induced cleavage of human factor VIII [3] Thrombosis and Haemostasis. 73: 730-731. PMID 7495090 DOI: 10.1055/S-0038-1653853 |
0.382 |
|
| 1994 |
Tans G, Nicolaes GAF, Thomassen MCLGD, Hemker HC, Van Zonneveld AJ, Pannekoek H, Rosing J. Activation of human factor V by meizothrombin Journal of Biological Chemistry. 269: 15969-15972. PMID 8206891 |
0.549 |
|
| 1994 |
Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa Proceedings of the National Academy of Sciences of the United States of America. 91: 2728-2732. PMID 8146182 DOI: 10.1073/Pnas.91.7.2728 |
0.455 |
|
| 1994 |
Govers-Riemslag JWP, Janssen MP, Zwaal RFA, Rosing J. Prothrombin activation on dioleoylphosphatidylcholine membranes European Journal of Biochemistry. 220: 131-138. PMID 8119280 DOI: 10.1111/J.1432-1033.1994.Tb18607.X |
0.39 |
|
| 1994 |
Bakker HM, Tans G, Thomassen MCLGD, Yukelson LY, Ebberink R, Hemker HC, Rosing J. Functional properties of human factor Va lacking the Asp683-Arg709 domain of the heavy chain Journal of Biological Chemistry. 269: 20662-20667. PMID 8051166 |
0.558 |
|
| 1993 |
Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C Journal of Biological Chemistry. 268: 2872-2877. PMID 8428962 |
0.373 |
|
| 1993 |
Rosing J, Bakker HM, Thomassen MCLGD, Hemker HC, Tans G. Characterization of two forms of human factor Va with different cofactor activities Journal of Biological Chemistry. 268: 21130-21136. PMID 8407949 |
0.588 |
|
| 1993 |
Bakker HM, Tans G, Yukelson LY, Janssen-Claessen TW, Bertina RM, Hemker HC, Rosing J. Protein C activation by an activator purified from the venom of Agkistrodon halys halys Blood Coagulation and Fibrinolysis. 4: 605-614. PMID 8218858 DOI: 10.1097/00001721-199308000-00012 |
0.651 |
|
| 1993 |
Tans G, Rosing J. Prothrombin activation by snake venom proteases Toxin Reviews. 12: 155-173. DOI: 10.3109/15569549309033110 |
0.393 |
|
| 1993 |
Yukel'son LY, Sadykov ES, Barabanshchikova NA, Rosing J, Tans G, Hemker HC. An investigation of the coagulological potential of the venoms of some Central Asian snakes Chemistry of Natural Compounds. 29: 384-390. DOI: 10.1007/BF00630546 |
0.383 |
|
| 1992 |
Rosing J, Tans G. Structural and functional properties of snake venom prothrombin activators Toxicon. 30: 1515-1527. PMID 1488760 DOI: 10.1016/0041-0101(92)90023-X |
0.385 |
|
| 1992 |
Gerads I, Tans G, Yukelson LY, Zwaal RFA, Rosing J. Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana Toxicon. 30: 1065-1079. PMID 1440644 DOI: 10.1016/0041-0101(92)90052-7 |
0.479 |
|
| 1992 |
Govers-Riemslag JWP, Janssen MP, Zwaal RFA, Rosing J. Effect of membrane fluidity and fatty acid composition on the prothrombin- converting activity of phospholipid vesicles Biochemistry. 31: 10000-10008. PMID 1390758 DOI: 10.1021/Bi00156A020 |
0.324 |
|
| 1992 |
Bakker HM, Tans G, Janssen-Claessen T, Thomassen MCLGD, Hemker HC, Griffin JH, Rosing J. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C European Journal of Biochemistry. 208: 171-178. PMID 1387359 DOI: 10.1111/J.1432-1033.1992.Tb17171.X |
0.61 |
|
| 1991 |
Tans G, Janssen-Claessen T, Coenraad Hemker H, Zwaal RFA, Rosing J. Meizothrombin formation during factor Xa-catalyzed prothrombin activation formation in a purified system and in plasma Journal of Biological Chemistry. 266: 21864-21873. PMID 1939210 |
0.347 |
|
| 1991 |
Yukelson LY, Tans G, Thomassen MCLGD, Hemker HC, Rosing J. Procoagulant activities in venoms from central Asian snakes Toxicon. 29: 491-502. PMID 1830705 DOI: 10.1016/0041-0101(91)90023-K |
0.61 |
|
| 1990 |
Zwaal RF, Bevers EM, Comfurius P, Rosing J, Tilly RH, Verhallen PF. Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Molecular and Cellular Biochemistry. 91: 23-31. PMID 2695831 DOI: 10.1007/Bf00228075 |
0.308 |
|
| 1990 |
Gerads I, Govers-Riemslag JWP, Tans G, Zwaal RFA, Rosing J. Prothrombin activation on membranes with anionic lipids containing phosphate, sulfate, and/or carboxyl groups Biochemistry. 29: 7967-7974. PMID 2261453 DOI: 10.1021/Bi00486A027 |
0.344 |
|
| 1989 |
Rosing J, Tans G, Speijer H, Zwaal RF. Calcium-independent activation of prothrombin on membranes with positively charged lipids. Biochemistry. 27: 9048-55. PMID 3233222 DOI: 10.1021/Bi00425A025 |
0.358 |
|
| 1989 |
Tans G, Janssen-Claessen T, Rosing J. Amidolytic Detection of Prothrombin Activation Products after SDS-Gel Electrophoresis Thrombosis and Haemostasis. 61: 386-391. DOI: 10.1055/S-0038-1646601 |
0.401 |
|
| 1988 |
Rosing J, Speijer H, Zwaal RF. Prothrombin activation on phospholipid membranes with positive electrostatic potential. Biochemistry. 27: 8-11. PMID 3162382 DOI: 10.1021/Bi00401A002 |
0.357 |
|
| 1988 |
Rosing J, Tans G. Meizothrombin, a Major Product of Factor Xa-Catalyzed Prothrombin Activation Thrombosis and Haemostasis. 60: 355-360. DOI: 10.1055/S-0038-1646971 |
0.386 |
|
| 1987 |
Govers-Riemslag JP, Knapen MJH, Tans G, Zwaal RFA, Rosing J. Structural and fuctional characterization of a prothrombin activator from the venom of Bothrops neuwiedi Biochimica Et Biophysica Acta. 916: 388-401. PMID 3689799 DOI: 10.1016/0167-4838(87)90185-3 |
0.422 |
|
| 1987 |
Tans G, Janssen-Claessen T, Rosing J, Griffin JH. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa. European Journal of Biochemistry. 164: 637-42. PMID 3552674 DOI: 10.1111/J.1432-1033.1987.Tb11174.X |
0.439 |
|
| 1987 |
Tans G, Rosing J. Structural and functional characterization of factor XII. Seminars in Thrombosis and Hemostasis. 13: 1-14. PMID 3551074 DOI: 10.1055/S-2007-1003471 |
0.441 |
|
| 1987 |
Speijer H, Govers-Riemslag JWP, Zwaal RFA, Rosing J. Platelet Procoagulant Properties Studied with Snake Venom Prothrombin Activators Thrombosis and Haemostasis. 57: 349-355. DOI: 10.1055/S-0038-1651132 |
0.408 |
|
| 1986 |
Bevers EM, Rosing J, Zwaal RF. Development of procoagulant binding sites on the platelet surface. Advances in Experimental Medicine and Biology. 192: 359-71. PMID 3914834 DOI: 10.1007/978-1-4615-9442-0_25 |
0.36 |
|
| 1986 |
van Rijn JL, Zwaal RF, Hemker HC, Rosing J. Role of accessory components in the activation of vitamin K-dependent coagulation factors. Haemostasis. 16: 216-26. PMID 3093336 DOI: 10.1159/000215294 |
0.577 |
|
| 1985 |
Govers-Riemslag JW, Speijer H, Zwaal RF, Rosing J. The effects of bovine prothrombin fragment 1 and fragment 1.2 on prothrombin activation. Thrombosis Research. 38: 375-88. PMID 3925588 DOI: 10.1016/0049-3848(85)90136-7 |
0.445 |
|
| 1985 |
Rosing J, Tans G, Griffin JH. Surface-dependent activation of human factor XII (Hageman factor) by kallikrein and its light chain. European Journal of Biochemistry. 151: 531-8. PMID 3875484 DOI: 10.1111/J.1432-1033.1985.Tb09135.X |
0.396 |
|
| 1985 |
Rosing J, van Rijn J, Bevers E, van Dieijen G, Comfurius P, Zwaal R. The role of activated human platelets in prothrombin and factor X activation Blood. 65: 319-332. DOI: 10.1182/blood.v65.2.319.319 |
0.333 |
|
| 1985 |
van Dieijen G, van Rijn JLML, Govers-Riemslag JWP, Hemker HC, Rosing J. Assembly of the Intrinsic Factor X Activating Complex – Interactions between Factor IXa, Factor VIIIa and Phospholipid Thrombosis and Haemostasis. 53: 396-400. DOI: 10.1055/S-0038-1661322 |
0.603 |
|
| 1984 |
van Rijn JL, Govers-Riemslag JW, Zwaal RF, Rosing J. Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on the formation of the enzyme-substrate complex. Biochemistry. 23: 4557-64. PMID 6498156 DOI: 10.1021/Bi00315A008 |
0.415 |
|
| 1983 |
Lindhout T, Govers-Riemslag JW, van de Waart P, Hemker HC, Rosing J. Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition. Biochemistry. 21: 5494-502. PMID 7171570 DOI: 10.1021/Bi00265A018 |
0.581 |
|
| 1983 |
van Dieijen-Visser MP, van Wersch J, Brombacher PJ, Rosing J, Hemker HC, van Dieijen G. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants. Haemostasis. 12: 241-55. PMID 7141303 DOI: 10.1159/000214679 |
0.591 |
|
| 1983 |
van Rijn J, Rosing J, van Dieijen G. Activity of human blood platelets in prothrombin and in factor X activation induced by ionophore A23187. European Journal of Biochemistry. 133: 1-10. PMID 6406226 DOI: 10.1111/J.1432-1033.1983.Tb07422.X |
0.392 |
|
| 1982 |
Tans G, Janssen-Claessen T, van Dieijen G, Hemker HC, Rosing J. Activation of Factor IX by Factor XIa - A Spectrophotometric Assay for Factor IX in Human Plasma Thrombosis and Haemostasis. 48: 127-132. DOI: 10.1055/S-0038-1657240 |
0.625 |
|
| 1977 |
Muller JL, Rosing J, Slater EC. The binding of aurovertin to isolated F1 (mitochondrial ATPase). Biochimica Et Biophysica Acta. 462: 422-37. PMID 145244 DOI: 10.1016/0005-2728(77)90140-2 |
0.467 |
|
| 1975 |
Rosing J, Harris DA, Slater EC, Kemp A. The possible role of tightly bound adenine nucleotides in oxidative and photosynthetic phosphorylation. Journal of Supramolecular Structure. 3: 284-96. PMID 127089 DOI: 10.1002/Jss.400030311 |
0.629 |
|
| 1975 |
Rosing J, Harris DA, Kemp A, Slater EC. Nucleotide-binding properties of native and cold-treated mitochondrial ATPase. Biochimica Et Biophysica Acta. 376: 13-26. PMID 123764 DOI: 10.1016/0005-2728(75)90201-7 |
0.629 |
|
| 1974 |
Leenders HJ, Kemp A, Koninkx JFJG, Rosing J. Changes in cellular ATP, ADP and AMP levels following treatments affecting cellular respiration and the activity of certain nuclear genes in Drosophila salivary glands Experimental Cell Research. 86: 25-30. PMID 4831162 DOI: 10.1016/0014-4827(74)90642-9 |
0.466 |
|
| 1974 |
Harris DA, Rosing J, Slater EC. Specific spin-labelling of the energy-coupling system of mitochondria. Febs Letters. 47: 236-40. PMID 4372095 DOI: 10.1016/0014-5793(74)81019-7 |
0.398 |
|
| 1974 |
Rosing J, Harris DA, Kemp A, Slater EC. Subunit interactions in mitochondrial adenosine triphosphatase Biochemical Society Transactions. 2: 502-505. DOI: 10.1042/Bst0020502 |
0.573 |
|
| 1974 |
Harris DA, Rosing J, Slater EC. Interaction of ox heart mitochondrial adenosine triphosphatase with nucleotides Biochemical Society Transactions. 2: 86-87. |
0.411 |
|
| 1973 |
Souverijn JHM, Huisman LA, Rosing J, Kemp A. Comparison of ADP and ATP as substrates for the adenine nucleotide translocator in rat-liver mitochondria Bba - Bioenergetics. 305: 185-198. PMID 4741129 DOI: 10.1016/0005-2728(73)90168-0 |
0.437 |
|
| 1973 |
Slater EC, Rosing J, Mol A. The phosphorylation potential generated by respiring mitochondria. Biochimica Et Biophysica Acta. 292: 534-53. PMID 4705444 DOI: 10.1016/0005-2728(73)90003-0 |
0.41 |
|
| 1973 |
Harris DA, Rosing J, van de Stadt RJ, Slater EC. Tight binding of adenine nucleotides to beef-heart mitochondrial ATPase. Biochimica Et Biophysica Acta. 314: 149-53. PMID 4270535 DOI: 10.1016/0005-2728(73)90130-8 |
0.429 |
|
| 1972 |
Rosing J, Slater EC. The value of G degrees for the hydrolysis of ATP. Biochimica Et Biophysica Acta. 267: 275-90. PMID 4402900 DOI: 10.1016/0005-2728(72)90116-8 |
0.411 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2007 |
Munnix IC, Kuijpers MJ, Auger J, Thomassen CM, Panizzi P, van Zandvoort MA, Rosing J, Bock PE, Watson SP, Heemskerk JW. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 2484-90. PMID 17761939 DOI: 10.1161/Atvbaha.107.151100 |
0.294 |
|
| 2001 |
Vandenbroucke JP, Rosing J, Bloemenkamp KWM, Middeldorp S, Helmerhorst FM, Bouma BN, Rosendaal FR. Oral contraceptives and the risk of venous thrombosis New England Journal of Medicine. 344: 1527-1535. PMID 11357157 DOI: 10.1056/Nejm200105173442007 |
0.289 |
|
| 2010 |
Maurissen LF, Castoldi E, Simioni P, Rosing J, Hackeng TM. Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals. Journal of Thrombosis and Haemostasis : Jth. 8: 750-8. PMID 20088940 DOI: 10.1111/j.1538-7836.2010.03743.x |
0.287 |
|
| 1987 |
Rosing J, Tans G, Griffin JH. The function of the heavy and light chain of human plasma kallikrein in the activation of factor XII. Advances in Experimental Medicine and Biology. 27-34. PMID 3492870 DOI: 10.1007/978-1-4757-0154-8_3 |
0.287 |
|
| 2012 |
Rossouw JE, Johnson KC, Pettinger M, Cushman M, Sandset PM, Kuller L, Rosendaal F, Rosing J, Wasserthal-Smoller S, Martin LW, Manson JE, Lakshminarayan K, Merino JG, Lynch J. Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy. Stroke; a Journal of Cerebral Circulation. 43: 952-7. PMID 22363056 DOI: 10.1161/Strokeaha.111.643072 |
0.284 |
|
| 2013 |
Sonnevi K, Tchaikovski SN, Holmström M, Antovic JP, Bremme K, Rosing J, Lärfars G. Obesity and thrombin-generation profiles in women with venous thromboembolism. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 24: 547-53. PMID 23470648 DOI: 10.1097/Mbc.0B013E32835F93D5 |
0.279 |
|
| 2010 |
van Vliet HA, Rosendaal FR, Fleischer K, Rosing J, Helmerhorst FM. Effects of the contraceptive vaginal ring, the contraceptive transdermal patch and combined oral contraceptives on markers of hemostasis. Contraception. 81: 88-9; author reply 8. PMID 20004280 DOI: 10.1016/J.Contraception.2009.05.131 |
0.272 |
|
| 2021 |
Castoldi E, Hézard N, Mourey G, Wichapong K, Poggi M, Ibrahim-Kosta M, Thomassen MCLGD, Fournel A, Hayward CPM, Alessi MC, Hackeng TM, Rosing J, Morange PE. Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besançon). Journal of Thrombosis and Haemostasis : Jth. PMID 33605529 DOI: 10.1111/jth.15274 |
0.272 |
|
| 2011 |
Smid M, Dielis AW, Winkens M, Spronk HM, van Oerle R, Hamulyák K, Prins MH, Rosing J, Waltenberger JL, ten Cate H. Thrombin generation in patients with a first acute myocardial infarction. Journal of Thrombosis and Haemostasis : Jth. 9: 450-6. PMID 21143375 DOI: 10.1111/J.1538-7836.2010.04162.X |
0.268 |
|
| 2001 |
Middeldorp S, Rosing J, Bouma BN, Büller HR. Effects of oral contraceptives of the second and third generations on the haemostasis | Effecten van orale anticonceptiva van de tweede en de derde generatie op de hemostase Nederlands Tijdschrift Voor Geneeskunde. 145: 252-256. PMID 11236370 |
0.267 |
|
| 1991 |
Tans G, Rosing J, Thomassen MCLGD, Heeb MJ, Zwaal RFA, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles Blood. 77: 2641-2648. PMID 2043766 |
0.26 |
|
| 1991 |
Tans G, Rosing J, Thomassen M, Heeb M, Zwaal R, Griffin J. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles Blood. 77: 2641-2648. DOI: 10.1182/Blood.V77.12.2641.Bloodjournal77122641 |
0.26 |
|
| 1986 |
Zwaal R, Bevers E, Rosing J. Platelet phospholipids in hemostasis and thrombosis Thrombosis Research. 41: 10. DOI: 10.1016/0049-3848(86)91366-6 |
0.26 |
|
| 1991 |
Rosing J, Tans G. Inventory of exogenous prothrombin activators. For the Subcommittee on Nomenclature of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thrombosis and Haemostasis. 65: 627-630. PMID 1871726 |
0.257 |
|
| 2004 |
Gris JC, Nouvellon-Cochery E, Marès P, Rosing J, Tans G, Kemmeren JM, Meijers JCM, Bouma BN, Curvers J, Grobbee DE, Algra A. Increased resistance to activated protein C in women taking third-generation oral contraceptives? [1] (multiple letters) Blood. 104: 1907-1909. PMID 15342364 DOI: 10.1182/blood-2004-01-0101 |
0.254 |
|
| 2019 |
Creinin MD, Rosing J, Jost M, Kinet V, Chatel G, Foidart JM. Estetrol Combined with Drospirenone: A New Oral Contraceptive With a Favorable Hemostatic Profile [20OP] Obstetrics & Gynecology. 133: 7-7. DOI: 10.1097/01.Aog.0000559087.93476.Bc |
0.252 |
|
| 2007 |
Castoldi E, Brugge JM, Tans G, Rosing J. Coagulation factor V and anticoagulation factor | Factor V stollingsfactor en antistollingsfactor Hart Bulletin. 38: 132-136. |
0.25 |
|
| 2013 |
Raps M, Helmerhorst FM, Fleischer K, van Hylckama Vlieg A, Van Hylckama VA, Stegeman BH, Thomassen S, Rosendaal FR, Rosing J, Ballieux BE, Van Vliet HA. Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: reply to a rebuttal. Journal of Thrombosis and Haemostasis : Jth. 11: 396-7. PMID 23176323 DOI: 10.1111/Jth.12080 |
0.249 |
|
| 2008 |
Johnson JV, Lowell J, Badger GJ, Rosing J, Tchaikovski S, Cushman M. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial. Obstetrics and Gynecology. 111: 278-84. PMID 18238963 DOI: 10.1097/Aog.0B013E3181626D1B |
0.248 |
|
| 2009 |
van Vliet HA, Rosendaal FR, Rosing J, Helmerhorst FM. Sex hormone-binding globulin: an adequate surrogate marker for venous thromboembolism in women using new hormonal contraceptives. Contraception. 79: 328-9; author reply . PMID 19272504 DOI: 10.1016/J.Contraception.2008.11.002 |
0.247 |
|
| 1993 |
Aronson DL, Brinkhous KM, Henschen A, Iwanaga S, Kornalik F, Markland FS, Markwardt F, Marsh N, Pirkle H, Rosing J, Teng CM, Stocker K. Nomenclature of exogenous hemostatic factors [6] Blood. 81: 272. PMID 8417799 DOI: 10.1055/s-0038-1646401 |
0.242 |
|
| 2003 |
Thomassen MC, Castoldi E, Tans G, Magdeleyns EJ, Delaunoit C, Debusscher L, Van Assche KJ, Rosing J. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool. Haematologica. 88: 1150-6. PMID 14555311 |
0.24 |
|
| 2003 |
Rosing J, Preston FE. Oral contraceptives, pregnancy, hormone replacement, and thrombosis Seminars in Vascular Medicine. 3: 1-2. DOI: 10.1055/S-2003-38336 |
0.239 |
|
| 2011 |
Tchaikovski S, Thomassen M, Brandkvist C, Bremme K, Rosing J. P.77 Changes in haemostatic parameters induced by drospirenone-containing oral contraceptives Thrombosis Research. 127: S147. DOI: 10.1016/S0049-3848(11)70132-3 |
0.236 |
|
| 2011 |
Rosing J, Tans G. Snake venom prothrombin activators - The history Toxins and Hemostasis: From Bench to Bedside. 485-499. DOI: 10.1007/978-90-481-9295-3_28 |
0.235 |
|
| 2012 |
Segers O, Simioni P, Tormene D, Bulato C, Gavasso S, Rosing J, Castoldi E. Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes. Journal of Thrombosis and Haemostasis : Jth. 10: 73-80. PMID 22044617 DOI: 10.1111/j.1538-7836.2011.04546.x |
0.235 |
|
| 1997 |
Rosing J. Anticoagulant factor Va derivatives Biofutur. 1997: 45. DOI: 10.1016/S0294-3506(99)80315-9 |
0.235 |
|
| 1985 |
Rosing J, Bevers E, Comfurius P, Hemker H, van Dieijen G, Weiss H, Zwaal R. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder Blood. 65: 1557-1561. DOI: 10.1182/BLOOD.V65.6.1557.BLOODJOURNAL6561557 |
0.231 |
|
| 2020 |
Douxfils J, Klipping C, Duijkers I, Kinet V, Mawet M, Maillard C, Jost M, Rosing J, Foidart JM. Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters. Contraception. PMID 32956694 DOI: 10.1016/J.Contraception.2020.08.015 |
0.23 |
|
| 2016 |
Harrington LB, Blondon M, Cushman M, Kaunitz AM, Rossouw JE, Allison MA, Martin LW, Johnson KC, Rosing J, Woods NF, LaCroix AZ, Heckbert SR, McKnight B, Smith NL. The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women. Menopause (New York, N.Y.). PMID 27922933 DOI: 10.1097/Gme.0000000000000777 |
0.229 |
|
| 2015 |
Johnson KC, Aragaki AK, Jackson R, Reiner A, Sandset PM, Rosing J, Dahm AE, Rosendaal F, Manson JE, Martin LW, Liu S, Kuller LH, Cushman M, Rossouw JE. Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 26681757 DOI: 10.1161/ATVBAHA.115.306905 |
0.225 |
|
| 2007 |
Marchetti M, Castoldi E, Spronk H, Balducci D, Barbui T, Rosing J, ten Cate H, Falanga A. PO-75 Thrombin generation in patients with essential thrombocythemia (ET) Thrombosis Research. 120: S169. DOI: 10.1016/S0049-3848(07)70228-1 |
0.211 |
|
| 2003 |
Post MS, Christella M, Thomassen LG, van der Mooren MJ, van Baal WM, Rosing J, Kenemans P, Stehouwer CD. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women. Arteriosclerosis, Thrombosis, and Vascular Biology. 23: 1116-21. PMID 12730085 DOI: 10.1161/01.ATV.0000074146.36646.C8 |
0.21 |
|
| 2007 |
Tchaikovski S, Tans G, Rosing J. 5B.2 Mechanism of hormonal therapy related thrombosis Thrombosis Research. 119: S64-S66. DOI: 10.1016/S0049-3848(07)70032-4 |
0.2 |
|
| 2007 |
Castoldi E, Simioni P, Tormene D, Thomassen M, Spiezia L, Gavasso S, Rosing J. MORE SEVERE HYPERCOAGULABLE STATE IN PROTHROMBIN G20210A CARRIERS THAN IN NON-CARRIERS WITH COMPARABLE PROTHROMBIN LEVELS Journal of Thrombosis and Haemostasis. 5: P-M-468-P-M-468. DOI: 10.1111/J.1538-7836.2007.Tb01389.X |
0.2 |
|
| 2003 |
Lindqvist PG, Rosing J, Malmquist A, Hillarp A. Etonogestrel implant use is not related to hypercoagulable changes in anticoagulant system Journal of Thrombosis and Haemostasis. 1: 601-602. PMID 12871477 DOI: 10.1046/J.1538-7836.2003.T01-2-00177.X |
0.186 |
|
| 1982 |
van Dieijen G, Tans G, van Rijn J, Zwaal RF, Rosing J. Simple and rapid method to determine the binding of blood clotting factor X to phospholipid vesicles. Biochemistry. 20: 7096-101. PMID 7317368 DOI: 10.1021/BI00528A007 |
0.182 |
|
| 1997 |
Rosing J. Teaching Biochemistry at a Medical Faculty with a problem-based learning system Biochemical Education. 25: 71-74. DOI: 10.1016/S0307-4412(96)00173-2 |
0.164 |
|
| 2001 |
Arocha-Pinango CL, Gempeler-Messina P, Henschen A, Markland FS, Marsh NA, Morita T, Rosing J, Manjunatha Kini R, Chow G. Exogenous factors from animal sources that induce platelet aggregation Thrombosis and Haemostasis. 85: 177-178. PMID 11204571 |
0.154 |
|
| 1977 |
Kayalar C, Rosing J, Boyer PD. An alternating site sequence for oxidative phosphorylation suggested by measurement of substrate binding patterns and exchange reaction inhibitions Journal of Biological Chemistry. 252: 2486-2491. PMID 856791 |
0.151 |
|
| 2001 |
Manjunatha Kini R, Morita T, Rosing J. Classification and nomenclature of prothrombin activators isolated from snake venoms Thrombosis and Haemostasis. 86: 710-711. PMID 11522026 |
0.145 |
|
| 2013 |
Rosing J. Scutelarin (Oscutarin) Handbook of Proteolytic Enzymes. 3: 3039-3041. DOI: 10.1016/B978-0-12-382219-2.00665-7 |
0.12 |
|
| 2010 |
Tsai TC, Rosing JH, Norton JA. Role of factor VII in correcting dilutional coagulopathy and reducing re-operations for bleeding following non-traumatic major gastrointestinal and abdominal surgery. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 14: 1311-8. PMID 20517651 DOI: 10.1007/s11605-010-1227-6 |
0.118 |
|
| 1977 |
Rosing J, Kayalar C, Boyer PD. Evidence for energy dependent change in phosphate binding for mitochondrial oxidative phosphorylation based on measurements of medium and intermediate phosphate water exchanges Journal of Biological Chemistry. 252: 2478-2485. PMID 140165 |
0.117 |
|
| 1977 |
ROSING J, VAN DAM K. The Adenosine Triphosphatase Complex: Structure and Function of a Membrane-Bound Enzyme Biochemical Society Transactions. 5: 517-517. DOI: 10.1042/BST0050517 |
0.114 |
|
| 1976 |
Rosing J, Smith DJ, Kayalar C, Boyer PD. Medium ADP and not ADP already tightly bound to phylakoid membranes forms the initial ATP in chloroplast phosphorylation Biochemical and Biophysical Research Communications. 72: I. PMID 10896 DOI: 10.1016/0006-291X(76)90952-9 |
0.114 |
|
| 1976 |
Kayalar C, Rosing J, Boyer PD. 2,4-dinitrophenol causes a marked increase in the apparent Km of Pi and of ADP for oxidative phosphorylation Biochemical and Biophysical Research Communications. 72: 1153-1159. PMID 985515 DOI: 10.1016/S0006-291X(76)80252-5 |
0.104 |
|
| 2001 |
Arocha-Pinango CL, Gempeler-Messina P, Henschen A, Markland FS, Marsh NA, Morita T, Rosing J, Manjunatha Kini R, Chow G. Exogenous inhibitors of platelet aggregation from animal sources Thrombosis and Haemostasis. 85: 179-181. PMID 11204572 |
0.098 |
|
| 2004 |
Vanschoonbeek K, Feijge MA, Paquay M, Rosing J, Saris W, Kluft C, Giesen PL, de Maat MP, Heemskerk JW. Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 1734-40. PMID 15217806 DOI: 10.1161/01.ATV.0000137119.28893.0b |
0.093 |
|
| 2011 |
Tchaikovski S, Thomassen M, Costa S, Brandkvist C, Bremme K, Rosing J. Changes in haemostatic parameters induced by drospirenone-containing oral contraceptives Geburtshilfe Und Frauenheilkunde. 71. DOI: 10.1055/s-0031-1286406 |
0.092 |
|
| 2006 |
MacLennan AJ, Benner SJ, Andringa A, Chaves AH, Rosing JL, Vesey R, Karpman AM, Cronier SA, Lee N, Erway LC, Miller ML. The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function. Hearing Research. 220: 38-48. PMID 16945494 DOI: 10.1016/j.heares.2006.06.016 |
0.086 |
|
| 2011 |
Rosing J. What's needed for reprocessing, storage of laryngoscope blades? Or Manager. 27: 15-6, 19. PMID 22250377 |
0.064 |
|
| 2005 |
Rosing J. Mechanisms of OC related thrombosis. Thrombosis Research. 115: 81-3. PMID 15790163 |
0.057 |
|
| 2019 |
Tahzib-Lie B, Rosing JR. A Competitive Race among Friends: The Campaign of the Kingdom of the Netherlands for a Seat on the UN Security Council The Hague Journal of Diplomacy. 14: 467-479. DOI: 10.1163/1871191x-14401068 |
0.052 |
|
| 2012 |
Rosing J. Joint Commission's top ten toughest standards. Or Manager. 28: 21, 23. PMID 22594091 |
0.045 |
|
| 2010 |
Rosing JH, Momeni A, Kamperman K, Kahn D, Gurtner G, Lee GK. Effectiveness of the Asteame Nipple Guard™ in maintaining projection following nipple reconstruction: a prospective randomised controlled trial. Journal of Plastic, Reconstructive & Aesthetic Surgery : Jpras. 63: 1592-6. PMID 19897430 DOI: 10.1016/j.bjps.2009.10.006 |
0.036 |
|
| 2010 |
Rosing JR. Five Steps, Plus One. Healthcare Executive. 25: 42-3. PMID 20649168 |
0.03 |
|
| 2013 |
Osman S, Chou S, Rosing J, Sahar DE. Total posterior leg open wound management with free anterolateral thigh flap: case and literature review. Eplasty. 13: e50. PMID 24106563 |
0.03 |
|
| 2011 |
Chen Y, Kingham K, Ford JM, Rosing J, Van Dam J, Jeffrey RB, Longacre TA, Chun N, Kurian A, Norton JA. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Annals of Surgical Oncology. 18: 2594-8. PMID 21424370 DOI: 10.1245/s10434-011-1648-9 |
0.025 |
|
| 2010 |
Rosing JR. CMS anesthesia rules are stiffened. Or Manager. 26: 20-1. PMID 20384228 |
0.022 |
|
| 2009 |
Rosing JH, Jeffrey RB, Longacre TA, Greco RS. Massive extra-adrenal retroperitoneal paraganglioma: pre-operative embolization and resection. Digestive Diseases and Sciences. 54: 1621-4. PMID 19408117 DOI: 10.1007/s10620-009-0804-6 |
0.02 |
|
| 2011 |
Rosing JR. Core measures, accreditation to be linked. Or Manager. 27: 6. PMID 21534414 |
0.019 |
|
| 2012 |
Chidambaran V, Rosing J, Soler X, Sadhasivam S. Muscle trauma from tourniquet (mis)use. Anesthesiology. 117: 179. PMID 22311093 DOI: 10.1097/ALN.0b013e318249d0e8 |
0.019 |
|
| 2011 |
Rosing JH, Wong G, Wong MS, Sahar D, Stevenson TR, Pu LL. Autologous fat grafting for primary breast augmentation: a systematic review. Aesthetic Plastic Surgery. 35: 882-90. PMID 21455825 DOI: 10.1007/s00266-011-9691-2 |
0.016 |
|
| 2014 |
Rosing J, Clemetson KJ, Kini RM. Preface Toxin Reviews. 33: 1. DOI: 10.3109/15569543.2014.860256 |
0.01 |
|
| 2012 |
Rosing JH, Lance S, Wong MS. Ulnar neuropathy after tube thoracostomy for pneumothorax. The Journal of Emergency Medicine. 43: e223-5. PMID 20347247 DOI: 10.1016/j.jemermed.2010.01.019 |
0.01 |
|
| 2011 |
Rosing JR. CMS updates anesthesia guidelines. Or Manager. 27: 23. PMID 21542520 |
0.01 |
|
| Hide low-probability matches. |